Well only .13 away from what imho will be the DIP and then the RIP
SHORTS YOU BEST PAY ATTENTION, this imho will be your last chance to cover anywhere NEAR THESE PRICES
GETERDUN BOYZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ
SHORTS YOU BEST PAY ATTENTION, this imho will be your last chance to cover anywhere NEAR THESE PRICES
GETERDUN BOYZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ
Recent CLSD News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:06:09 PM
- Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process • GlobeNewswire Inc. • 11/24/2025 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 08:10:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2025 11:24:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2025 11:16:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2025 08:30:28 PM
- Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress • GlobeNewswire Inc. • 08/26/2025 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 08:05:49 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/04/2025 12:00:10 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/25/2025 08:11:36 PM
- Clearside Biomedical Receives Canadian Approval for XIPERE® to Treat Uveitic Macular Edema via Suprachoroidal Delivery • IH Market News • 07/23/2025 12:08:34 PM
- Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada • GlobeNewswire Inc. • 07/23/2025 11:05:00 AM
- Clearside Biomedical shares dip after announcing exploration of strategic alternatives • IH Market News • 07/17/2025 12:38:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2025 11:15:26 AM
- Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline • GlobeNewswire Inc. • 07/17/2025 11:05:00 AM
- Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting • GlobeNewswire Inc. • 06/17/2025 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 08:05:12 PM
